Baidu
map

Blood:确诊下肢深静脉血栓时,立即予以压迫治疗可减少残余静脉闭塞

2018-09-21 MedSci MedSci原创

中心点:深静脉血栓后立即进行压迫治疗与残余静脉闭塞的绝对减少20%相关。24个月时,残余血栓的减少与血栓后综合征绝对减少8%相关。摘要:残余静脉闭塞与确诊深静脉血栓时立即加压治疗以及血栓后综合征之间的关联尚不明确。确诊深静脉血栓后立即进行加压治疗是否会影响残余静脉闭塞(ROV)的发生?RVO的出现是否与血栓后综合征和复发性静脉栓塞相关?Elham E. Amin等研究人员对此进行深入研究。IDEA

中心点:

深静脉血栓后立即进行压迫治疗与残余静脉闭塞的绝对减少20%相关。

24个月时,残余血栓的减少与血栓后综合征绝对减少8%相关。

摘要:

残余静脉闭塞与确诊深静脉血栓时立即加压治疗以及血栓后综合征之间的关联尚不明确。确诊深静脉血栓后立即进行加压治疗是否会影响残余静脉闭塞(ROV)的发生?RVO的出现是否与血栓后综合征和复发性静脉栓塞相关?Elham E. Amin等研究人员对此进行深入研究。

IDEAL DVT临床试验的一个预先指定的子研究从荷兰的10个学术和非学术中心招募了592位客观证实下肢近端深静脉血栓形成的成年患者,在确诊深静脉血栓形成的24小时内,未采取压迫治疗或采用多层绷带/加压袜(压强35mmHg)进行急性压迫。以压迫超声明确是否存在RPV或静脉血栓复发,以6-24个月中Villalta评分>5的患者比例作为血栓后综合征的发生率

从确诊到评估RVO的平均时间为5.3(SD1.9)个月。确诊深静脉血栓后立即进行压迫治疗的患者发生RVO的比例明显降低(46.3% vs 66.7%;OR 0.46,95% CI 0.27-0.80,p=0.005)。无RVO的患者少见血栓后综合征(46.0% vs 54.0%;OR 0.65,95% CI 0.46-0.92,p=0.013)。复发性静脉血栓与RVO无明显相关性。

综上所述,所有急性下肢深静脉血栓患者,在确诊时均应立即予以压迫治疗,且不考虑并发症的严重程度。


原始出处:

Elham E. Amin, et al.Residual vein occlusion in relation to immediate compression and postthrombotic syndrome in deep vein thrombosis.Blood  2018  :blood-2018-03-836783;  doi: https://doi.org/10.1182/blood-2018-03-836783

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697761, encodeId=bb2d169e761eb, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Oct 27 23:46:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955380, encodeId=47c319553805a, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Oct 06 03:46:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347077, encodeId=ec3d34e07738, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272c1984235, createdName=陈长孺, createdTime=Fri Sep 28 08:02:03 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346028, encodeId=0839346028b6, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Fri Sep 21 17:42:32 CST 2018, time=2018-09-21, status=1, ipAttribution=)]
    2018-10-27 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697761, encodeId=bb2d169e761eb, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Oct 27 23:46:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955380, encodeId=47c319553805a, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Oct 06 03:46:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347077, encodeId=ec3d34e07738, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272c1984235, createdName=陈长孺, createdTime=Fri Sep 28 08:02:03 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346028, encodeId=0839346028b6, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Fri Sep 21 17:42:32 CST 2018, time=2018-09-21, status=1, ipAttribution=)]
    2018-10-06 xue8602
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697761, encodeId=bb2d169e761eb, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Oct 27 23:46:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955380, encodeId=47c319553805a, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Oct 06 03:46:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347077, encodeId=ec3d34e07738, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272c1984235, createdName=陈长孺, createdTime=Fri Sep 28 08:02:03 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346028, encodeId=0839346028b6, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Fri Sep 21 17:42:32 CST 2018, time=2018-09-21, status=1, ipAttribution=)]
    2018-09-28 陈长孺

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1697761, encodeId=bb2d169e761eb, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Oct 27 23:46:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955380, encodeId=47c319553805a, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Oct 06 03:46:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=347077, encodeId=ec3d34e07738, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272c1984235, createdName=陈长孺, createdTime=Fri Sep 28 08:02:03 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346028, encodeId=0839346028b6, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Fri Sep 21 17:42:32 CST 2018, time=2018-09-21, status=1, ipAttribution=)]
    2018-09-21 王秀

    学习了,涨知识了!

    0

相关资讯

Invest Radiol:3D SPACE序列在诊断下肢深静脉血栓的价值。

下肢深静脉血栓形成是常见病此病可后遗下肢水肿、继发性静脉曲张、皮炎、色素沉着、郁滞性溃疡等,严重损害劳动人民健康,深静脉血栓形成的部位以下肢髂股静脉段最多见。本研究为了评价非强化序列SPACE诊断下肢深静脉血栓(DVT)以及评价血凝块负荷的价值,并将研究结果发表在Invest Radiol。本研究共纳入了94例怀疑下肢DVT的患者(42 例男性, 52 女性; 年龄范围: 14-87岁; 平均年龄

Baidu
map
Baidu
map
Baidu
map